Parkinsonism: a clinical marker of exposure to neurotoxins
- PMID: 3073307
- DOI: 10.1016/0892-0362(88)90011-6
Parkinsonism: a clinical marker of exposure to neurotoxins
Retraction in
-
Retraction. Parkinsonism: a clinical marker of exposure to neurotoxins.Neurotoxicol Teratol. 1990 Nov-Dec;12(6):569. doi: 10.1016/0892-0362(90)90063-i. Neurotoxicol Teratol. 1990. PMID: 2255298 No abstract available.
Abstract
Parkinson must be viewed as a final common pathway resulting from a variety of neuropathological lesions which interfere with the integrity of the nigrostriatal system or its output. Exposure to a wide variety of neurotoxic compounds, namely, carbon monoxide, carbon disulfide, manganese and MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), are associated with parkinsonism that has a varying neuropathology, which will be discussed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
